# Patient's Anastrozole Compliance to Therapy Programme

> **NCT00555867** · — · TERMINATED · sponsor: **AstraZeneca** · enrollment: 4923 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Anastrozole

## Key facts

- **NCT ID:** NCT00555867
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2006-10
- **Primary completion:** 2011-02
- **Final completion:** 2011-02
- **Target enrollment:** 4923 (ACTUAL)
- **Why stopped:** High drop-out rate leads to the conclusion: not enough data will be available to perform proper analyses of data collected after follow-up month 24 visit
- **Last updated:** 2011-12-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00555867

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00555867, "Patient's Anastrozole Compliance to Therapy Programme". Retrieved via AI Analytics 2026-08-03 from https://api.ai-analytics.org/clinical/NCT00555867. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*